Rein Therapeutics Inc.
RNTX | NASDAQ
$0.79
$0 (-0.57%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -6.08M | -5.23M | -3.96M | -5.49M | -6.87M | -5.61M | -5.8M | -6.07M | -9.04K | -7.21K | -7.29K | -1.98K | -1.99K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 700 | n/a | n/a | n/a | 600 | n/a | n/a |
Pretax Income | -6.38M | -5.84M | -32.68M | -5.58M | -6.82M | -5.5M | -42.53M | -5.85M | -8.94K | -7.11K | -7.34K | -1.83K | -1.79K |
Net Income | -6.38M | -5.84M | -31.97M | -5.58M | -6.82M | -5.5M | -40.98M | -5.85M | -8.94K | -7.11K | -7.34K | -1.83K | -1.79K |
Selling & General & Admin | 2.44M | 2.16M | 1.96M | 3.81M | 2.58M | 2.56M | 2.48M | 2.35M | 5.3K | 3.74K | 5.33K | 1.96K | 1.89K |
Research & Development | 3.64M | 3.07M | 2M | 1.68M | 4.29M | 3.05M | 3.32M | 3.72M | 3.74K | 3.46K | 1.97K | 22 | 187 |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12 | 6 | -88 |
Operating Expenses | 6.08M | 5.23M | 3.96M | 5.49M | 6.87M | 5.61M | 5.8M | 6.07M | 9.04K | 7.21K | 7.29K | 1.98K | 1.99K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.08M | 5.23M | 3.96M | 5.49M | 6.87M | 5.61M | 5.8M | 6.07M | 9.04K | 7.21K | 7.29K | 1.98K | 1.99K |
Income Tax Expense | n/a | n/a | -712K | n/a | n/a | n/a | -1.54M | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 67.08M | 30.35M | 25.44M | 26.36M | 24.19M | 22.94M | 21.69M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M |
Shares Outstanding (Diluted) | 67.08M | 30.35M | 25.44M | 26.36M | 24.19M | 22.94M | 21.69M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M |
EPS (Basic) | -0.10 | -0.19 | -1.22 | -0.21 | -0.28 | -0.24 | -1.89 | -0.27 | -0.45 | -0.86 | -1.54 | -0.40 | -0.39 |
EPS (Diluted) | -0.10 | -0.19 | -1.22 | -0.21 | -0.28 | -0.24 | -1.89 | -0.27 | -0.45 | -0.86 | -1.54 | -0.40 | -0.39 |
EBITDA | -6.38M | -5.22M | -3.87M | -5.58M | -6.82M | -5.5M | -42.53M | -5.85M | -8.94K | -7.05K | -7.25K | -1.97K | -2.07K |
EBIT | -6.38M | -5.84M | -3.87M | -5.58M | -6.82M | -5.5M | -42.53M | -5.85M | -8.94K | -7.11K | -7.3K | -1.98K | -2.08K |
Depreciation & Amortization | n/a | 623K | n/a | n/a | 1K | n/a | n/a | n/a | 4 | 59 | 52 | 12 | 12 |
Add to Watchlist
Select watchlists to add or remove RNTX